MedPath

PSV on Ventilation Inhomogeneity and Lung Function in Patients Under SB Across LMA

Not Applicable
Completed
Conditions
Respiratory Function Tests
Ventilation
Anesthesia, General
Patient Positioning
Interventions
Procedure: general anesthesia across LMA
Procedure: Spontaneous breathing(SB)
Procedure: Pressure Support Ventilation
Registration Number
NCT02986269
Lead Sponsor
Walid HABRE
Brief Summary

General anesthesia has been demonstrated to have a negative impact on lung function. Both surgery and patient position influence the perioperative lung function. Laryngeal mask airway (LMA) has been proved to be safe and efficient to maintain the airways patent during general anesthesia. Pressure support ventilation (PSV) with LMA is routinely used in clinical practice. The aim of the present trial is to characterize perioperative changes in lung volume, ventilation inhomogeneity and respiratory mechanics in patients in the lithotomy position and spontaneously breathing through LMA with and without PSV.

Detailed Description

This study is a randomized controlled trial. Participants for this study will be recruited from the Gynecological department of the University Hospitals of Geneva, scheduled for gynecological procedures in the lithotomy position under general anesthesia. A total of 40 patients will be enrolled and randomly assigned into 2 groups: Group SB (spontaneously breathing without PSV) and Group PSV (spontaneously breathing with PSV). Measurements of end-expiratory lung volume (EELV) and ventilation inhomogeneity will be performed in all patients with a nitrogen multiple breath washout method, before and 1 hour after surgery. Similarly, airway resistance (Rrs) and reactance (Xrs) will be measured at the same time by using the Forced Oscillation Technique.

The primary endpoint: Perioperative changes in ventilation inhomogeneity (LCI) and respiratory mechanics (Rrs and Xrs) of patients, positioned in lithotomy and undergoing general anesthesia while breathing spontaneously through LMA with or without PSV.

The secondary endpoints: Presence of respiratory complications, oxygen need in the recovery room, length of stay in the recovery room and in the hospital. Correlation between duration of positioning and surgery with lung function and volume measurements.

Relevance: There are no studies that addressed the value of pressure support ventilation to overcome the potential changes in lung function following spontaneous ventilation across a LMA in the lithotomy position.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • American Society of Anesthesiologists physical status (ASA) Ⅰ and Ⅱ grade, adult female patients, aged between 18 and 50 years scheduled for elective gynecological surgery in the lithotomy position.
Exclusion Criteria
  1. Age<18 years and >50 years old
  2. ASA score of III-V
  3. Patients with a potentially difficult airway (cervical spine disease, Mallampati classification III or IV or mouth opening of <2.5 cm)
  4. Risk of regurgitation/aspiration(previous upper gastrointestinal tract surgery, known or symptomatic hiatus hernia, oesophageal reflux, peptic ulceration or not fasted)
  5. Respiratory diseases(bronchial asthma requiring therapy)
  6. Patient refusal
  7. Malignant hyperthermia history
  8. Sore throat within 10 days
  9. Body mass index (BMI) >30 kg/m2
  10. Cardiac disease associated with dyspnea more than New York Heart Association II
  11. Severe psychiatric disorder.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group PSVSpontaneous breathing(SB)General anesthesia across LMA under SB with PSV Patient is scheduled for elective conisation or hysteroscopy under general anesthesia. The ventilation mode for this group is SB with PSV under LMA.
Group PSVPressure Support VentilationGeneral anesthesia across LMA under SB with PSV Patient is scheduled for elective conisation or hysteroscopy under general anesthesia. The ventilation mode for this group is SB with PSV under LMA.
Group SBgeneral anesthesia across LMAPatient is scheduled for elective conisation or hysteroscopy under general anesthesia. The ventilation mode for this group is spontaneous breathing(SB) without pressure support ventilation (PSV) under laryngeal mask airway (LMA). General anesthesia across LMA under SB without PSV
Group SBSpontaneous breathing(SB)Patient is scheduled for elective conisation or hysteroscopy under general anesthesia. The ventilation mode for this group is spontaneous breathing(SB) without pressure support ventilation (PSV) under laryngeal mask airway (LMA). General anesthesia across LMA under SB without PSV
Group PSVgeneral anesthesia across LMAGeneral anesthesia across LMA under SB with PSV Patient is scheduled for elective conisation or hysteroscopy under general anesthesia. The ventilation mode for this group is SB with PSV under LMA.
Primary Outcome Measures
NameTimeMethod
Perioperative changes in ventilation inhomogeneity (LCI)Through study completion, an average of 12 hours

LCI will be derived from the nitrogen multiple breath washout technique that will be applied before and after general anesthesia for gynecology in the lithotomy position with patients breathing spontaneously through a LMA with and without pressure support.

Secondary Outcome Measures
NameTimeMethod
Changes in airway resistance (Raw)Through study completion, an average of 12 hours

Raw will be measured by the forced oscillation technique

Alterations in end expiratory lung volume in ml/kg (EELV)Through study completion, an average of 12 hours

EELV will be measured from the nitrogen multiple breath washout technique that will be applied before and after general anesthesia for gynecology in the lithotomy position with patients breathing spontaneously through a LMA with and without pressure support.

Changes in respiratory system compliance (Crs)Through study completion, an average of 12 hours

Crs will be measured by the forced oscillation technique

Perioperative respiratory complicationsThrough study completion, an average of 12 hours

any respiratory complications (apnoea/ bradypnoea, bronchospasm, laryngospasm, oxygen desaturation \<90%/ hypoxemia, hypoventilation/ atelectasis, pulmonary embolism, cough and /or airway obstruction

Trial Locations

Locations (1)

University Hospitals of Geneva

🇨🇭

Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath